Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.57 USD | -0.04% | -1.04% | +12.84% |
14/03 | Barrington Ups Price Target on Anika Therapeutics to $37 From $29, Keeps Outperform Rating | MT |
13/03 | Transcript : Anika Therapeutics, Inc., Q4 2023 Earnings Call, Mar 13, 2024 |
Sales 2024 * | 170M 14.2B | Sales 2025 * | 182M 15.16B | Capitalization | 375M 31.26B |
---|---|---|---|---|---|
Net income 2024 * | -2M -167M | Net income 2025 * | 6M 500M | EV / Sales 2024 * | 2.2 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.06 x |
P/E ratio 2024 * |
-167
x | P/E ratio 2025 * |
61.9
x | Employees | 357 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.4% |
Latest transcript on Anika Therapeutics, Inc.
1 day | -0.04% | ||
1 week | -1.04% | ||
Current month | +0.67% | ||
1 month | +0.83% | ||
3 months | +4.80% | ||
6 months | +36.01% | ||
Current year | +12.84% |
Managers | Title | Age | Since |
---|---|---|---|
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31/18/31 |
Michael Levitz
DFI | Director of Finance/CFO | 50 | 10/20/10 |
Anne Nunes
COO | Chief Operating Officer | 55 | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Vogt
BRD | Director/Board Member | 70 | 23/18/23 |
Sheryl Conley
BRD | Director/Board Member | 63 | 28/21/28 |
Cheryl Blanchard
CEO | Chief Executive Officer | 59 | 31/18/31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 27 M€ | -5.03% | - |
Date | Price | Change | Volume |
---|---|---|---|
26/24/26 | 25.57 | -0.04% | 36,883 |
25/24/25 | 25.58 | -1.24% | 48,662 |
24/24/24 | 25.9 | +0.43% | 31,400 |
23/24/23 | 25.79 | -0.62% | 35,868 |
22/24/22 | 25.95 | +0.43% | 37,540 |
Delayed Quote Nasdaq, April 27, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+12.84% | 375M | |
-4.66% | 86.13B | |
+1.32% | 39.82B | |
-19.27% | 30.42B | |
+57.86% | 25.23B | |
-16.09% | 15.35B | |
-9.14% | 11.95B | |
-17.69% | 11.6B | |
-43.00% | 11.51B | |
+5.24% | 8.71B |
- Stock Market
- Equities
- ANIK Stock